Strategic Analysis of the Massachusetts Fixed-Base Ratio: The 16% Limit in the Context of the Section 38M Research Credit

The Massachusetts Fixed-Base Ratio is a statutory mechanism that caps a corporation’s historical research intensity at 16% to establish a baseline for determining incremental R&D tax credits. It represents the maximum allowable percentage of gross receipts that a company must exceed in current-year research spending to qualify for the state’s 10% incremental tax incentive.1

This ratio serves as the critical variable in the “Traditional Method” of calculating the Massachusetts Research Credit under General Laws Chapter 63, Section 38M. By setting a 16% ceiling, the Commonwealth provides a “safety valve” for highly innovative firms—such as those in the biotechnology, software, and life sciences sectors—whose historical research-to-revenue ratios might otherwise create an unreachable spending threshold for earning future credits.7 Furthermore, the 16% figure acts as a regulatory default for taxpayers who lack the historical records required to reconstruct their financial data from the early years of their existence.6 Understanding the nuances of this ratio requires a deep dive into the legislative history of the 2014 Economic Development Act, the administrative regulations promulgated by the Department of Revenue (DOR), and the interaction between state-level incentives and federal Internal Revenue Code (IRC) standards.2

The Statutory Framework of the Massachusetts Research Credit

The foundational authority for the Massachusetts research credit is M.G.L. c. 63, § 38M, which grants business corporations a credit against their corporate excise tax for qualified research expenses (QREs) incurred within the Commonwealth.1 While the state credit largely mirrors the federal research credit available under Section 41 of the IRC, it maintains several distinct characteristics regarding its calculation methods, the definition of the base amount, and the treatment of specific industries like defense and life sciences.3

Historically, the Massachusetts research credit was static, tied to the federal definitions of the IRC as they existed on August 12, 1991.6 This meant that for over two decades, corporations were required to use a “fixed-base percentage” that often relied on financial data from the 1984–1988 period to establish their baseline.7 For many companies, maintaining such ancient records was a significant administrative burden, and for newer companies, the “start-up” rules were often complex and less favorable than those for established firms.7

A major turning point occurred with the passage of the Economic Development Act of 2014 (St. 2014, c. 287), which rewrote § 38M to modernize the credit and introduce more flexibility.1 This legislation introduced the “Alternative Simplified Method” (ASM) and replaced the old “fixed-base percentage” with a rolling “fixed-base ratio” for the Traditional Method.2 These changes became effective for tax years beginning on or after January 1, 2015, marking a shift toward a more accessible and documentation-friendly incentive structure.1

Summary of Credit Calculation Options

1

Mechanics of the Fixed-Base Ratio

The Fixed-Base Ratio is the engine of the Traditional Method. It is designed to measure the “research intensity” of a business during a specific historical period and apply that intensity to the company’s recent revenue to establish what constitutes “normal” or “baseline” R&D spending.2

The Rolling Look-Back Calculation

Under the modern rules (post-2015), the fixed-base ratio is no longer tied to the 1980s. Instead, it is calculated using a rolling look-back window focused on the 3rd and 4th taxable years preceding the credit year.2 The formula is as follows:

$$\text{Fixed-Base Ratio} = \frac{\text{Total QREs for years } t-3 \text{ and } t-4}{\text{Total Gross Receipts for years } t-3 \text{ and } t-4}$$

The resulting percentage must be rounded to the nearest 1/100 of 1% (four decimal places).8 For example, a calculated ratio of 0.07452 would be expressed as 7.45%. This rolling mechanism ensures that as a company evolves, its research credit baseline evolves with it, preventing a company from being permanently locked into a spending intensity that no longer reflects its business model.7

Significance of the 16% Maximum Limit

The 16% cap is a critical protection for taxpayers. In high-growth sectors, early-stage companies often spend a massive percentage of their revenue on R&D—sometimes more than 100% of their gross receipts if they are pre-revenue or in early commercialization.7 Without a cap, these companies would have a fixed-base ratio so high that they would effectively never be able to earn a research credit in future years, as their “baseline” would exceed their current year’s spending capacity.7

The law explicitly states that “in no event shall the fixed-base ratio exceed 16 per cent”.1 By limiting the ratio to 16%, the Commonwealth acknowledges that research intensity eventually plateaus and that a 16% baseline is a reasonable maximum “hurdle” for any corporation to clear before its spending is considered incremental and worthy of a 10% tax credit.2

The “Inadequate Records” Default

Beyond its role as a cap for high-intensity firms, the 16% limit serves as an administrative default for companies that cannot calculate their ratio.6 Massachusetts regulation 830 CMR 63.38M.2(6)(c)2 provides that if a corporation cannot compute the fixed-base ratio due to inadequate accounts and records, the ratio is automatically set at 16%.2

This default is a “double-edged sword.” While it allows a company with missing data to still claim a credit, it forces that company to use the highest possible baseline, which maximizes the non-creditable spending amount and reduces the overall tax benefit.8 Consequently, companies are strongly incentivized to maintain robust financial records for their R&D spending and gross receipts.5

Insufficient Gross Receipts and Ineligibility

The Traditional Method requires a functional calculation of gross receipts for the 3rd and 4th preceding years.2 If a taxpayer’s gross receipts for those years equal zero, they are ineligible to use the Traditional Method and must instead calculate their credit using the Alternative Simplified Method.2 This ensures that the Traditional Method is reserved for operational companies with at least some historical sales data to support a ratio calculation.2

Determining the Base Amount

The Fixed-Base Ratio is the first step in establishing the “Base Amount,” which is the threshold the current year’s spending must exceed to generate a credit.1

The Base Amount Calculation Formula

The base amount is the product of the Fixed-Base Ratio and the average annual gross receipts of the taxpayer for the four taxable years preceding the credit year.1

$$\text{Base Amount} = \text{Fixed-Base Ratio (up to 16\%)} \times \text{Avg Annual Receipts (years } t-1, t-2, t-3, t-4)$$

However, the statute provides a critical “floor” for this calculation. The base amount can never be less than 50% of the qualified research expenses for the current year.2 This 50% minimum base amount rule ensures that even companies with very low historical R&D intensity or massive recent revenue growth cannot claim a credit on more than half of their current-year R&D expenditures.2

The Election for Massachusetts Gross Receipts

When calculating the base amount and the fixed-base ratio, corporations have a significant choice: they may use federal gross receipts or elect to use only Massachusetts-sourced gross receipts.2 This election is made in the first year the credit is claimed and is generally binding for three consecutive tax years.8

Choosing Massachusetts receipts can drastically change the Fixed-Base Ratio. If a company does 100% of its research in Massachusetts but only 10% of its sales occur within the state, its Fixed-Base Ratio using Massachusetts receipts will be much higher (and likely capped at 16%) compared to a ratio calculated using total federal receipts.3 However, its average annual receipts figure for the base amount calculation will be much lower.3 Taxpayers must model both scenarios to determine which election provides the most advantageous (lowest) base amount.7

Defining Qualified Research Expenses (QREs)

The data used to populate the fixed-base ratio must consist only of “Massachusetts Qualified Research Expenses”.5 Massachusetts largely adopts the definitions of IRC § 41(b), but with the strict requirement that the research activities must be physically conducted within the Commonwealth.1

In-State Activity Requirements

For an expense to qualify, it must meet both the federal “four-part test” for R&D and the state “location test”.6

5

Defense-Related Activities and Medical Countermeasures

A unique provision in M.G.L. c. 63, § 38M allows corporations to elect to calculate their research credit separately for “defense-related activities”.3 This allows a company to isolate high-intensity defense R&D from more stable commercial R&D, potentially maximizing the credit across both segments.3

In recent years, the definition of “defense-related activities” was expanded beyond traditional munitions to include:

1. Medicines and medical supplies for diagnosing or treating diseases related to chemical, biological, radiological, or nuclear threats.3
2. Biologic products, vaccines, and antibodies.3
3. NASA-related equipment and services.5

This expansion is particularly relevant for the Massachusetts biotechnology hub, as it allows many life sciences companies to categorize their research as “defense-related” if they are working on biosecurity or pandemic preparedness contracts.3

Comparative Example: The 16% Cap and Base Amount Floor

To illustrate how the 16% limit and the 50% base amount floor interact, consider the following calculation for a Massachusetts-based hardware engineering firm in the 2024 tax year.

Taxpayer Financial Profile

2

Step 1: Calculate the Fixed-Base Ratio

$$\text{Fixed-Base Ratio} = \frac{\$2,000,000 + \$1,500,000}{\$8,000,000 + \$7,000,000} = \frac{\$3,500,000}{\$15,000,000} = 0.2333 \text{ or } 23.33\%$$

Step 2: Apply the 16% Statutory Limit

Because the calculated ratio of 23.33% exceeds the statutory maximum, the corporation must cap its Fixed-Base Ratio at 16% (0.1600).1

Step 3: Determine the Tentative Base Amount

$$\text{Tentative Base Amount} = 0.1600 \times \$15,000,000 = \$2,400,000$$

Step 4: Apply the 50% Minimum Floor

The base amount cannot be less than 50% of the current year’s QREs ($5,000,000).2

$$\text{Minimum Base Floor} = 0.50 \times \$5,000,000 = \$2,500,000$$

Since the $2,500,000 floor is higher than the $2,400,000 tentative base, the final Base Amount for this corporation is $2,500,000.2

Step 5: Final Credit Calculation

$$\text{Incremental QREs} = \$5,000,000 – \$2,500,000 = \$2,500,000$$

$$\text{Research Credit} = 10\% \times \$2,500,000 = \$250,000 \text{ [1, 2, 3]}$$

In this case, the 16% cap was overridden by the 50% floor. However, had the company’s revenue been higher (e.g., $20,000,000 average), the 16% cap would have resulted in a base of $3,200,000, which would have been the final threshold.2

Controlled Groups and Aggregation Rules

Massachusetts law requires that the research credit be calculated on an aggregate basis for “controlled groups” or entities under “common control”.1 This mirrors federal aggregation rules and prevents taxpayers from artificially inflating their credit by separating research activities from revenue-generating activities.5

The Aggregation Mechanism

The group is treated as a single taxpayer for the purposes of the calculation.5 The fixed-base ratio is determined by aggregating the QREs and gross receipts of all group members.5 For example, if Member A has a 20% ratio and Member B has a 5% ratio, the group’s aggregate ratio will fall somewhere in between, still subject to the 16% cap.8

Allocation of the Group Credit

Once the total group credit is determined, it is allocated to individual members based on their proportionate share of the total QREs and basic research payments that generated the credit.8 Under the rules for corporations filing a combined return (M.G.L. c. 63, § 32B), a member with excess research credit may apply that credit against the excise of another group member, provided the other member has not already reached its own statutory limitation.2

Limitations on Applying the Research Credit

Earning the credit is distinct from utilizing it. Massachusetts imposes several layers of limitations that govern how much of the generated credit can actually be used to offset excise tax in any given year.2

The $25,000 and 75% Limit

The most significant limitation is found in § 38M(d). A corporation’s research credit is limited to:

1. 100% of the first $25,000 of excise liability.2
2. 75% of any excise liability that exceeds $25,000.2

For example, if a company has a $125,000 tax liability, it can use its research credits to offset the first $25,000, plus 75% of the remaining $100,000 (which is $75,000). The total credit usable for the year would be $100,000, leaving a net tax liability of $25,000.2

The Minimum Excise Floor

No credit, including the research credit, can reduce a corporation’s excise below the statutory minimum tax of $456.2 This applies to both the income measure and the non-income measure of the corporate excise.6

Carryover and Expiration Rules

Unused credits are not lost but are subject to two different carryover regimes.2

• Indefinite Carryforward: Credits that were disallowed specifically because of the 75% limitation can be carried forward indefinitely.3 This is a powerful feature for large corporations with sustained R&D investments.11
• 15-Year Carryforward: Credits that simply exceed the total tax liability for the year can be carried forward for 15 succeeding taxable years.4

The Life Sciences Tax Incentive Program

Massachusetts provides special treatment for the life sciences sector through the Massachusetts Life Sciences Center (MLSC).11 While most R&D credits are non-refundable, certified life sciences companies may apply to make their § 38M research credits refundable.11

Refundability Mechanics

If a life sciences company is approved for the incentive, it can receive a cash refund equal to 90% of the value of its excess research credits.31 This is a vital liquidity tool for pre-profit biotech startups that have high R&D spending but no tax liability to offset.33 The program requires a competitive application process, and companies must hit specific job creation and investment milestones.11

2025 Application Window and Incentives

The MLSC program for 2025-2026 is expected to open applications in mid-December 2025, with a closing date in mid-February 2026.33

29

Administrative and Revenue Guidance

The Department of Revenue has issued several technical information releases (TIRs) and proposed regulations to clarify the 2014 legislative changes and the application of the 16% ratio.2

TIR 14-13 and TIR 14-16

These releases provide the primary administrative interpretation of the Act Promoting Economic Growth Across the Commonwealth.13 TIR 14-13 explains the fundamental rewrite of § 38M and the introduction of the Fixed-Base Ratio.13 TIR 14-16 provides technical corrections, particularly regarding the multi-year phasing of the Alternative Simplified Method rates (5% to 7.5% to 10%).13

Regulation 830 CMR 63.38M.2

This “Proposed Regulation” (which is currently the operating guidance for post-2015 tax years) provides the specific formulas for the Fixed-Base Ratio and the Base Amount.6 Specifically, subsection (6)(c) confirms the 16% cap and the 16% default for inadequate records, while subsection (6)(e) mandates the use of federal accounting methods (accrual vs. cash) to maintain consistency with the federal research credit.6

Schedule RC Instructions

The annual instructions for Schedule RC (Research Credit) provide the procedural steps for claiming the credit.2 Line 12 of the Traditional Method calculation explicitly instructs taxpayers to enter their fixed-base percentage or ratio, capped at 16%.2

Economic and Fiscal Impact on Massachusetts

The Massachusetts research credit is a significant component of the state’s economic strategy, aimed at maintaining its status as a “global hub of innovation”.35

Revenue and Expenditure Data

In the 2025 Fiscal Year, the Department of Revenue certified that total tax collections reached $43.708 billion, a notable increase driven largely by capital gains and the new “fair share” surtax.36 However, corporate and business tax collections—the bucket from which research credits are deducted—actually decreased by 3.5% in FY 2025 compared to FY 2024, totaling approximately $4.662 billion.36

This decrease suggests that corporations are actively utilizing incentives like the R&D credit to manage their tax liabilities in an environment where other tax measures (like the surtax) have increased the overall burden on high-income entities.36 The “Innovation Economy” accounts for roughly 40% of jobs in Massachusetts, highlighting the critical nature of the R&D credit in retaining high-wage employment in the technology and life sciences sectors.35

The Innovation Index Trends

The 2023 Index of the Massachusetts Innovation Economy notes that research investment in the Commonwealth has grown by more than 56% since 2015.35 Massachusetts now attracts more research investment relative to the size of its economy than any other state in the nation.35 This suggests that the 2014 reforms—including the modernization of the fixed-base ratio and the 16% limit—have been successful in fostering a climate where R&D spending is both incentivized and predictable.7

Strategic Considerations for Businesses

Navigating the 16% Fixed-Base Ratio requires proactive tax planning and a deep understanding of a corporation’s historical and projected financial data.

Modeling Calculation Options

Companies should not automatically default to the Alternative Simplified Method simply because it appears “simpler”.7 For companies with flat or slightly increasing R&D spending but significant revenue growth, the Traditional Method—leveraging the 16% cap—may produce a significantly lower base amount and therefore a much higher credit.7

Conversely, for companies with rapidly increasing R&D spending (such as those in aggressive hiring phases), the Alternative Simplified Method (Option 2) often provides a superior benefit because its base amount (50% of the 3-year QRE average) is not influenced by gross receipts.11

Recordkeeping as Risk Management

Given the DOR’s stance that a lack of records defaults a company to the 16% ratio (the highest possible hurdle), it is imperative that businesses maintain detailed project-level documentation.6 This documentation should include:

• Employee job descriptions and time-tracking data.18
• Proof that research activities were conducted physically in Massachusetts.5
• Detailed general ledger support for supplies and contractor payments.5

Many practitioners recommend retaining these records for 5 to 7 years, as the DOR frequently examines multiple prior years when a credit carryforward is utilized in a current-year audit.11

Conclusion

The Massachusetts Fixed-Base Ratio and its 16% statutory limit represent a thoughtful compromise between protecting state revenue and fostering an environment of continuous innovation. By capping the research intensity factor, the Commonwealth ensures that even its most innovative firms are not “punished” by their historical success with an impossible-to-clear spending threshold. As the state’s economy continues to evolve, particularly with the expansion of defense-related R&D into the life sciences, the 16% cap will remain a cornerstone of the Massachusetts tax code, providing the predictability and accessibility necessary to maintain the Commonwealth’s leadership in the global innovation economy.

R&D Tax Credit Preparation Services

Swanson Reed is one of the only companies in the United States to exclusively focus on R&D tax credit preparation. Swanson Reed provides state and federal R&D tax credit preparation and audit services to all 50 states.

If you have any questions or need further assistance, please call or email our CEO, Damian Smyth on (800) 986-4725.
Feel free to book a quick teleconference with one of our national R&D tax credit specialists at a time that is convenient for you.

R&D Tax Credit Audit Advisory Services

creditARMOR is a sophisticated R&D tax credit insurance and AI-driven risk management platform. It mitigates audit exposure by covering defense expenses, including CPA, tax attorney, and specialist consultant fees—delivering robust, compliant support for R&D credit claims. Click here for more information about R&D tax credit management and implementation.

Our Fees

Swanson Reed offers R&D tax credit preparation and audit services at our hourly rates of between $195 – $395 per hour. We are also able offer fixed fees and success fees in special circumstances. Learn more at https://www.swansonreed.com/about-us/research-tax-credit-consulting/our-fees/